WeVote
Log In

Bill

Bill

SB 161

Pharmacy benefit management; requiring pharmacy benefit managers to maintain certain fiduciary duty. Effective date.

2025 Regular Session Introduced by Carri Hicks and 1 co-sponsor

Oklahoma bill requires pharmacy benefit managers to legally prioritize plan sponsors' and members' interests over profits, aiming to reduce drug costs and improve medication access.

Placed on General Order
0
WeVote Research Nonpartisan
Bill Summary · SB 161

Legislative bill overview

SB 161 requires pharmacy benefit managers (PBMs) to maintain fiduciary duties when managing prescription drug benefits for health plans and insurers. The bill imposes legal obligations on PBMs to act in the best interest of plan sponsors and members rather than prioritizing their own financial interests.

Why is this important

PBMs control drug pricing, formularies, and patient access to medications, making them powerful intermediaries between insurers, pharmacies, and patients. Without fiduciary requirements, PBMs can engage in practices like steering patients to higher-cost medications or limiting generic drug access to maximize profits. This bill attempts to align PBM incentives with patient and plan sponsor interests, potentially reducing prescription drug costs and improving medication access.

Potential points of contention

  • PBM industry opposition: Major PBMs argue fiduciary duties would limit business flexibility and could increase administrative costs passed to consumers and employers
  • Scope ambiguity: The bill may create disputes over what constitutes breach of fiduciary duty and how extensively it applies to PBM subsidiary operations and rebate negotiations
  • Enforcement mechanisms: The legislation's effectiveness depends on clear enforcement provisions and remedies for violations, which may be undefined or inadequate in the current draft

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.